On this page
Executive Summary
“Atypical parkinsonism” refers to a group of conditions, progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal degeneration (CBD), that share Parkinson's-like symptoms such as slowness, stiffness and balance problems but are distinct, faster-progressing diseases with a different underlying cause. Because they can initially resemble Parkinson's disease, misdiagnosis is common; red flags include early falls, poor response to levodopa, early cognitive or speech changes, and, in PSP, difficulty moving the eyes. A movement-disorder specialist can help clarify the diagnosis, and while none of these conditions can currently be slowed or reversed, an accurate diagnosis meaningfully changes what a care plan should actually prepare for.
What “Parkinsonism” Means, and Why “Atypical” Is a Different Category
“Parkinsonism” is a broader clinical term than “Parkinson's disease”, it describes a set of movement features (slowness, rigidity, tremor, balance problems) that can arise from more than one underlying cause. Parkinson's disease is the most common cause of parkinsonism, but it isn't the only one. CurePSP explains that PSP, CBD and MSA are brain diseases that can cause parkinsonism-like changes alongside additional symptoms, speech, swallowing, vision, cognition, and autonomic changes, that don't typically define classic Parkinson's disease, especially not early on. Because of this overlap, people with these conditions may initially be diagnosed with Parkinson's disease before the fuller clinical picture, and the label “atypical parkinsonism,” becomes clear.
These conditions are neurodegenerative, meaning symptoms change and worsen over time, and, unlike Parkinson's disease, where symptom management can often be sustained for many years, they tend to progress more quickly and respond poorly, or not at all, to the medications that work well for typical Parkinson's disease.
Progressive Supranuclear Palsy (PSP)
PSP is a tauopathy, a disease driven by abnormal accumulation of tau protein in the brain, the same protein class implicated in some forms of frontotemporal Dementia, reflecting a genuine biological overlap between these conditions.
Early signs: falls, eye-movement changes, personality shifts
The first noticeable symptom in a majority of PSP cases is a loss of balance, often described as lunging forward when walking, bumping into objects, or falling backward, sometimes very early in the disease course, well before the tremor-dominant picture typical of Parkinson's disease. Difficulty moving the eyes, particularly looking downward, is a hallmark feature that eventually distinguishes PSP clinically, though it may not be obvious in the earliest stages. Personality changes, apathy, disinhibition, and a general slowing of movement often accompany or precede the balance problems.
How PSP differs from Parkinson's disease
Falls happen much earlier and more frequently in PSP than in typical Parkinson's disease, where falls are more characteristic of later-stage disease. PSP also generally responds poorly to levodopa, in contrast to Parkinson's disease, where levodopa responsiveness is one of the defining diagnostic clues. The characteristic eye-movement abnormality has no equivalent in typical Parkinson's disease.
Multiple System Atrophy (MSA)
MSA is a synucleinopathy, like Parkinson's disease itself and Dementia with Lewy bodies, it involves abnormal alpha-synuclein accumulation, though the pattern and clinical presentation differ meaningfully from either.
Early signs: severe autonomic dysfunction, coordination problems
MSA often brings prominent, early, and severe autonomic symptoms, significant drops in blood pressure upon standing (see our guide to orthostatic hypotension for how this presents in Parkinson's disease more generally, noting that MSA's version tends to be considerably more severe and earlier), bladder dysfunction, and, in some presentations, prominent coordination and balance problems affecting speech and movement precision.
How MSA differs from Parkinson's disease
While orthostatic hypotension can occur in Parkinson's disease, its early appearance and severity in MSA is markedly more pronounced, a person with MSA may experience significant fainting risk and bladder dysfunction well before movement symptoms alone would suggest a severe disease stage. MSA also tends to progress considerably faster than typical Parkinson's disease.
Corticobasal Degeneration (CBD) and Corticobasal Syndrome
CBD, like PSP, is a tauopathy, and clinical overlap between the two conditions is well recognized. The clinical presentation it produces during life is often referred to as corticobasal syndrome (CBS), since the underlying pathology can only be confirmed with certainty after death.
Early signs: one-sided stiffness, apraxia, “alien limb”
CBD/CBS typically presents asymmetrically, stiffness, clumsiness, or jerking movements pronounced on one side of the body well beyond what's typical even for Parkinson's disease, which itself often starts on one side but usually progresses more symmetrically over time. Apraxia, difficulty performing purposeful movements despite having the physical strength to do so, is a defining feature. Some people experience “alien limb” phenomenon, in which a limb seems to move involuntarily, as though it has a will of its own separate from conscious control.
How CBD differs from Parkinson's disease
The pronounced asymmetry, the apraxia, and the alien limb phenomenon have no real equivalent in typical Parkinson's disease. Cognitive and language changes also tend to appear earlier and more prominently in CBD than in Parkinson's disease.
Comparison Table: Parkinson's Disease vs. PSP vs. MSA vs. CBD
| Feature | Parkinson's disease | PSP | MSA | CBD/CBS |
|---|
| Underlying protein | Alpha-synuclein | Tau | Alpha-synuclein | Tau |
| Early falls | Later in the disease course | Early, often the first symptom | Common, tied to autonomic and coordination problems | Variable |
| Levodopa response | Generally good | Generally poor | Generally poor | Generally poor |
| Symmetry | Often starts on one side, becomes more symmetric | Typically symmetric | Typically symmetric | Markedly one-sided |
| Distinctive features | Rest tremor, strong levodopa response | Abnormal eye movement, early falls | Severe early autonomic dysfunction | Apraxia, alien limb |
| Typical progression | Slower, often years to decades of good function | Faster | Faster | Faster |
This table summarizes general clinical patterns; any individual's presentation can vary, and diagnosis should always come from a specialist evaluation rather than from matching symptoms to this table.
Why Misdiagnosis Is So Common
Because these conditions share core parkinsonism features with Parkinson's disease, slowness, stiffness, balance difficulty, and because their most distinguishing features (abnormal eye movement, severe early autonomic failure, marked asymmetry and apraxia) may not be obvious in the earliest stages, an initial Parkinson's disease diagnosis is common and, in many cases, a reasonable working diagnosis at the time it's made. It's only as the fuller clinical picture unfolds, and, often, as the person fails to respond to levodopa the way a person with Parkinson's disease typically would, that the diagnosis is reconsidered.
Red Flags That Should Prompt a Specialist Referral
Falls occurring very early in the disease course, a poor or minimal response to an adequate trial of levodopa, prominent early cognitive or speech changes, marked asymmetry with apraxia, or severe early autonomic symptoms (significant fainting, bladder dysfunction) are all reasons to request evaluation by a movement-disorder specialist rather than continuing with a general Parkinson's disease treatment plan alone.
Getting the Right Diagnosis: The Role of Movement-Disorder Specialists
PSP, MSA and CBD are diagnosed by a neurologist, typically a movement-disorder specialist, based on clinical history and examination over time; this article is educational and cannot diagnose any of these conditions. There is no single definitive test for any of the three during life, diagnosis relies on the specialist's ability to recognize the specific pattern of symptoms and their progression, sometimes supported by brain imaging that can help rule out other causes. A poor or diminishing response to standard Parkinson's medication is a reason to request a specialist evaluation, not a reason to increase dosing independently.
Movement-disorder specialists with experience in these rarer conditions often practice within larger academic medical centers, so seeing one may involve some travel. Coordinating those appointments alongside home-based care is a real logistical undertaking worth planning for.
Home Safety and Care Implications
Fall risk in PSP specifically
Because falls happen early and are often backward falls tied to the balance and eye- movement features of PSP, home safety planning, removing loose rugs, securing hand- holds, considering a lower bed, often needs to happen sooner in the disease course than families expect based on general parkinsonism guidance alone.
Autonomic and blood-pressure management in MSA
Given how early and severe autonomic symptoms can be in MSA, careful attention to safe position changes, hydration, and blood pressure monitoring (see our guide to orthostatic hypotension for general strategies, recognizing MSA's presentation is often more severe) becomes a central, not secondary, part of daily care.
Asymmetric mobility loss in CBD
Because CBD affects one side of the body so much more than the other, adaptive strategies, one-handed techniques, asymmetric home modifications, careful attention to the “unaffected” side taking on more of the physical burden over time, are often more relevant than the more symmetric approaches typical of general Parkinson's care.
What This Means for Families Building a Care Plan
More than two decades of specialized Dementia and Parkinson's care has shown Angels on Call Homecare how differently PSP, MSA and CBD present day to day compared with typical Parkinson's disease, and why a care plan built for one doesn't automatically fit the others. Parkinson's-trained homecare, paired with RN-led clinical oversight for the fall-risk monitoring and autonomic management these conditions often require earlier than typical Parkinson's disease, reflects the kind of comprehensive, condition-specific approach families need once one of these diagnoses is confirmed or even strongly suspected.
Frequently Misunderstood Issues
Families sometimes assume that because these conditions share the word “parkinsonism,” they'll eventually respond to the same treatments that help typical Parkinson's disease, they generally don't, and that's an important expectation to reset with the treating neurologist early. It's also commonly misunderstood that a specific genetic test can confirm these diagnoses during life; in most cases, diagnosis remains clinical, based on the pattern and progression of symptoms rather than a single definitive lab result.
For the movement symptoms that most overlap with typical Parkinson's disease specifically, see freezing of gait, orthostatic hypotension, Parkinson's “on” and “off” periods, hallucinations in Parkinson's disease, Parkinson's and swallowing problems, the autonomic side of Parkinson's, REM sleep behavior disorder, and Parkinson's disease Dementia vs. Dementia with Lewy bodies.
This article is educational and does not replace medical advice. Always consult the treating physician or care team about symptoms, medications, and changes in condition.
